Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Rades

Showing results (261-270 of 609) with videos related to

Pageof 61
Sort By:
In Vivo (Athens, Greece)|August 28, 2025
Risk Factors for Radiation Pneumonitis and a Prognostic Instrument for Very Elderly Patients With Lung CancerDirk Rades, Cansu Delikanli, Laura Doehring, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladderDirk Rades, Thekla Meyners, Theo Veninga, et al.
In Vivo (Athens, Greece)|June 28, 2021
Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast CancerDirk Rades, Carlos A Narvaez, Steven E Schild, et al.
Anticancer Research|December 4, 2018
Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the BladderDirk Rades, Lisa Sondermann, Laura Motisi, et al.
Radiation Oncology (London, England)|September 22, 2014
A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery aloneStefan Huttenlocher, Liesa Dziggel, Dagmar Hornung, et al.
Anticancer Research|May 2, 2018
Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell CarcinomaDirk Rades, Liesa Dziggel, Oliver Blanck, et al.
Radiation Oncology (London, England)|August 17, 2022
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapyDirk Rades, Barbara Segedin, Steven E Schild, et al.
Frontiers in Oncology|May 14, 2024
The impact of tumor budding and single-cell invasion on survival in patients with stage III/IV locally advanced oral squamous cell carcinoma- results from a prospective cohort studySamer G Hakim, Ubai Alsharif, Mohamed Falougy, et al.
Anticancer Research|March 16, 2016
A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast CancerDirk Rades, Liesa Dziggel, Stefan Janssen, et al.
Anticancer Research|April 30, 2016
Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck CancerDaniel Seidl, Stefan Janssen, Primoz Strojan, et al.
Pageof 61

Showing results (261-270 of 609) with videos related to

Sort By:
Pageof 61
In Vivo (Athens, Greece)|August 28, 2025
Risk Factors for Radiation Pneumonitis and a Prognostic Instrument for Very Elderly Patients With Lung CancerDirk Rades, Cansu Delikanli, Laura Doehring, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladderDirk Rades, Thekla Meyners, Theo Veninga, et al.
In Vivo (Athens, Greece)|June 28, 2021
Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast CancerDirk Rades, Carlos A Narvaez, Steven E Schild, et al.
Anticancer Research|December 4, 2018
Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the BladderDirk Rades, Lisa Sondermann, Laura Motisi, et al.
Radiation Oncology (London, England)|September 22, 2014
A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery aloneStefan Huttenlocher, Liesa Dziggel, Dagmar Hornung, et al.
Anticancer Research|May 2, 2018
Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell CarcinomaDirk Rades, Liesa Dziggel, Oliver Blanck, et al.
Radiation Oncology (London, England)|August 17, 2022
Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapyDirk Rades, Barbara Segedin, Steven E Schild, et al.
Frontiers in Oncology|May 14, 2024
The impact of tumor budding and single-cell invasion on survival in patients with stage III/IV locally advanced oral squamous cell carcinoma- results from a prospective cohort studySamer G Hakim, Ubai Alsharif, Mohamed Falougy, et al.
Anticancer Research|March 16, 2016
A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast CancerDirk Rades, Liesa Dziggel, Stefan Janssen, et al.
Anticancer Research|April 30, 2016
Prognostic Factors After Definitive Radio(Chemo)Therapy of Locally Advanced Head and Neck CancerDaniel Seidl, Stefan Janssen, Primoz Strojan, et al.
Pageof 61